These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32353600)

  • 21. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
    Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
    Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
    Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
    J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of intensity modulated radiotherapy and dynamic three-dimensional conformal radiotherapy with regard to dose distribution and sparing of organs at risk.
    Hasegawa Y; Iuchi T; Osato K; Kodama T; Toyama N; Hatano K
    Neurol Med Chir (Tokyo); 2011; 51(5):349-55. PubMed ID: 21613759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies.
    Vogel J; Lin L; Simone CB; Berman AT
    Acta Oncol; 2017 Aug; 56(8):1060-1064. PubMed ID: 28338373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation.
    Rønde HS; Kallehauge JF; Kronborg CJS; Nyvang L; Rekstad BL; Hanekamp BA; Appelt AL; Guren MG; Spindler KLS
    Acta Oncol; 2021 Nov; 60(11):1436-1439. PubMed ID: 34264785
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
    Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of dose-sparing by protons assessed by a knowledge-based planning tool in radiotherapy of brain tumours.
    Smulders B; Stolarczyk L; Seiersen K; Nørrevang O; Sommer Kristensen B; Schut DA; Thomsen K; Lassen-Ramshad Y; Høyer M; Muhic A; Vestergaard A
    Acta Oncol; 2023 Nov; 62(11):1541-1545. PubMed ID: 37793798
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessing second cancer risk after primary cancer treatment with photon or proton radiotherapy.
    DeLaney TF; Yock TI; Paganetti H
    Cancer; 2020 Aug; 126(15):3397-3399. PubMed ID: 32426850
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
    Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
    Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
    Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
    van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
    Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
    [No Abstract]   [Full Text] [Related]  

  • 38. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
    Cozzi L; Fogliata A; Lomax A; Bolsi A
    Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation therapy for deep periocular cancer treatments when protons are unavailable: is combining electrons and orthovoltage therapy beneficial?
    Martell K; Poirier Y; Zhang T; Hudson A; Spencer D; Jacso F; Hayashi R; Banerjee R; Khan R; Wolfe N; Voroney JP
    J Radiat Res; 2018 Sep; 59(5):593-603. PubMed ID: 30053071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.